Utilities Healthcare Sector

HealthEquity

Market Cap: US$7.8b

Provides technology-enabled services platforms to consumers and employers in the United States.

Corcept Therapeutics

Market Cap: US$7.8b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Henry Schein

Market Cap: US$7.7b

Provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide.

Globus Medical

Market Cap: US$7.6b

A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Halozyme Therapeutics

Market Cap: US$7.5b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Cytokinetics

Market Cap: US$7.2b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Merus

Market Cap: US$7.2b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Avidity Biosciences

Market Cap: US$7.1b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Sonic Healthcare

Market Cap: AU$10.7b

Offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally.

Waystar Holding

Market Cap: US$6.8b

Develops a cloud-based software solution for healthcare payments.

Rhythm Pharmaceuticals

Market Cap: US$6.7b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

CRISPR Therapeutics

Market Cap: US$6.6b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Stevanato Group

Market Cap: US$6.5b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

ConvaTec Group

Market Cap: UK£4.8b

Engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally.

Nuvalent

Market Cap: US$6.4b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Chemed

Market Cap: US$6.2b

Provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.

Axsome Therapeutics

Market Cap: US$6.1b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Legend Biotech

Market Cap: US$5.9b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

BrightSpring Health Services

Market Cap: US$5.8b

Operates as a home and community-based healthcare services platform in the United States.

Vaxcyte

Market Cap: US$5.7b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

iRhythm Technologies

Market Cap: US$5.7b

A digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.

Metsera

Market Cap: US$5.6b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

RadNet

Market Cap: US$5.4b

Provides outpatient diagnostic imaging services in the United States and internationally.

Protagonist Therapeutics

Market Cap: US$5.4b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Hikma Pharmaceuticals

Market Cap: UK£4.0b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Bruker

Market Cap: US$5.4b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Teleflex

Market Cap: US$5.3b

Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.

PTC Therapeutics

Market Cap: US$5.3b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.

Krystal Biotech

Market Cap: US$5.3b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Alkermes

Market Cap: US$5.2b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Bausch + Lomb

Market Cap: US$5.1b

Operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally.

TG Therapeutics

Market Cap: US$4.9b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Arrowhead Pharmaceuticals

Market Cap: US$4.9b

Develops medicines for the treatment of intractable diseases in the United States.

Ramsay Health Care

Market Cap: AU$7.4b

Owns and operates hospitals in Australia and internationally.

Arcellx

Market Cap: US$4.8b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Glaukos

Market Cap: US$4.7b

An ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.